News
Doximity Full-Year 2024 Earnings: EPS Beats Expectations
Doximity (NYSE: DOCUMENTS) Complete results for the year 2024
Main financial results
-
Revenue: $475.4 million (14% increase from fiscal 2023).
-
Net profit: US$147.6 million (31% increase compared to fiscal year 2023).
-
Profit margin: 31% (vs. 27% in fiscal 2023). The margin increase was driven by increased revenue.
-
EPS: $0.78 (up from $0.58 in FY2023).
details of income and expenses
All numbers shown in the chart above are for the period of the last 12 months (TTM)
Doximity EPS exceeds expectations
Revenue was in line with analysts’ estimates. Earnings per share (EPS) surpassed analyst estimates by 7.5%.
Over the past 12 months, the only revenue segment was Healthcare Software, contributing $475.4 million. The largest operating expense was Sales and Marketing costs, amounting to US$132.2 million (48% of total expenses). Explore how DOCS income and expenses shape your earnings.
Looking ahead, revenue is forecast to grow 9.6% per year on average over the next 3 years, compared to a 10% growth forecast for the US healthcare industry.
Performance of American healthcare industry.
The company’s share price remains largely unchanged from the previous week.
Balance Sheet Analysis
Just as investors should consider profits, it is also important to consider the strength of a company’s balance sheet. We have a graphical representation of Doximity’s balance sheet and an in-depth analysis of the company’s financial position.
Do you have feedback on this article? Worried about the content? Get in touch with us directly. Alternatively, email the editorial team (at) Simplywallst.com.
This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts using only an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take into account your objectives or your financial situation. Our goal is to bring you long-term focused analysis driven by fundamental data. Please note that our analysis may not take into account the latest price-sensitive company announcements or qualitative materials. Simply Wall St has no position in any of the stocks mentioned.